Hi SC & Aaron, respect both opinions.
It's a bit simplistic but lets say the price (which BTW is the analysts opinion, not from the company) is only $500 a dose. The NPV would then be approximately $0.52. It seems the analysts believes that the target should be 50% of that so we arrive at 26c.
We're not far off what it is worth if it was priced at $500 a dose. No off-label use, no other indications etc etc.
I'm ok with this, for the moment anyway.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$11.80 |
Change
-0.450(3.67%) |
Mkt cap ! $585.4M | |||
| Open | High | Low | Value | Volume |
| $12.25 | $12.28 | $11.44 | $1.026M | 86.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 420 | $11.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.80 | 62 | 2 |
View Market Depth
| Last trade - 11.33am 23/07/2025 (20 minute delay) ? |
| CUV (ASX) Chart |